PRMDA: personalized recommendation-based MiRNA-disease association prediction

Zhu-Hong You1, Luo-Pin Wang2, Xing Chen3

  • 1Department of Information Engineering, Xijing University, Xi'an, China.

Oncotarget
|November 22, 2017
PubMed

Insights

Researchers developed a new computational model, Personalized Recommendation-based MiRNA-Disease Association prediction (PRMDA), to identify links between microRNAs (miRNAs) and diseases. This tool accurately predicts potential miRNA associations for various conditions, aiding disease research.

Area of Science:

  • Bioinformatics
  • Genomics
  • Computational Biology

Background:

  • MicroRNAs (miRNAs) play crucial roles in biological processes.
  • Dysregulation of miRNAs is linked to complex human diseases.
  • Accurate prediction of miRNA-disease associations is vital for biological and medical research.

Purpose of the Study:

  • To develop a computational model for predicting miRNA-disease associations.
  • To create a global method for prioritizing candidate miRNAs for all diseases simultaneously.
  • To enable prediction for diseases lacking known miRNA associations.

Main Methods:

  • Developed a Personalized Recommendation-based MiRNA-Disease Association prediction (PRMDA) model.
  • Implemented a personalized recommendation algorithm integrating disease and miRNA similarity.
  • Validated the model using leave-one-out cross-validation and case studies on human cancers.

Main Results:

  • PRMDA achieved an Area Under the Curve (AUC) of 0.8315, indicating high reliability.
  • Case studies on five human cancers (Colon Neoplasms, Esophageal Neoplasms, Lymphoma, Lung Neoplasms, Breast Neoplasms) showed high prediction accuracy.
  • 92-96% of top 50 predicted miRNAs were confirmed by experimental reports for the studied cancers.

Conclusions:

  • PRMDA is a reliable computational tool for predicting miRNA-disease associations.
  • The model demonstrates significant potential for identifying novel miRNA-disease links.
  • PRMDA can assist in understanding disease mechanisms and developing targeted therapies.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.3K